Creative Medical Technology Holdings, Inc. (CELZ) vs Nuvilex Inc. (PMCB)

Creative Medical Technology Holdings, Inc. and Nuvilex Inc. are both Biotechnology companies. Creative Medical Technology Holdings, Inc. and Nuvilex Inc. are of similar size ($4.0M and $4.0M). Nuvilex Inc. grew revenue faster over the last twelve months: −71.1% against −79.4%. Across the 11 metrics below, Nuvilex Inc. leads on 7 and Creative Medical Technology Holdings, Inc. on 4.

Valuation

Metric CELZ PMCB Biotechnology median
P/E n/m n/m 10.60
P/S 135.00 n/m 9.40
P/B 0.26 0.14 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 1.05 3.77 0.66
EV/Sales (377.99) n/m 9.02
Earnings yield (333.87%) (650.59%) (32.88%)
Free cash flow yield (489.01%) (266.52%) (23.13%)

Profitability

Metric CELZ PMCB Biotechnology median
Gross margin 61.18% 95.64% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (77.91%) (58.04%) (51.96%)
Return on assets (73.30%) (50.43%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CELZ PMCB Biotechnology median
Revenue growth (TTM) (79.42%) (71.06%) 6.76%
EPS growth (last fiscal year) 32.08% (186.83%) 29.88%
Revenue growth, 5-year CAGR (48.43%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CELZ PMCB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 12.91 40.29 4.97
Net debt to EBITDA 1.20 5.41 1.01

Dividend

Metric CELZ PMCB Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CELZ PMCB Biotechnology median
Market cap 4.00m 4.03m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack